Angiotensin-Converting Enzyme Inhibitors Increase Vasoconstriction Requirements After Cardiopulmonary Bypass

Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Converting Enzyme Inhibitors and Cardiopulmonary Bypass: Is ACE Inhibitor Safe for Heart Surgery?

Current Enzyme Inhibition ◽

10.2174/157340805774580475 ◽

2005 ◽

Vol 1 (3) ◽

pp. 253-256

Author(s):

Yasuyuki Shimada ◽

Hideshi Itoh

Keyword(s):

Cardiopulmonary Bypass ◽

Heart Surgery ◽

Ace Inhibitor ◽

Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin-Converting Enzyme Inhibitors Increase Vasoconstrictor Requirements After Cardiopulmonary Bypass

Anesthesia & Analgesia ◽

10.1213/00000539-199503000-00007 ◽

1995 ◽

Vol 80 (3) ◽

pp. 473-479 ◽

Cited By ~ 98

Author(s):

Kenneth J. Tuman ◽

Robert J. McCarthy ◽

Christopher J. OʼConnor ◽

Wendy E. Holm ◽

Anthony D. Ivankovich

Keyword(s):

Cardiopulmonary Bypass ◽

Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin-Converting Enzyme Inhibitors Increase Vasoconstrictor Requirements After Cardiopulmonary Bypass

Anesthesia & Analgesia ◽

10.1097/00000539-199503000-00007 ◽

1995 ◽

Vol 80 (3) ◽

pp. 473-479 ◽

Cited By ~ 14

Author(s):

Kenneth J. Tuman ◽

Robert J. McCarthy ◽

Christopher J. OʼConnor ◽

Wendy E. Holm ◽

Anthony D. Ivankovich

Keyword(s):

Cardiopulmonary Bypass ◽

Enzyme Inhibitors ◽

Converting Enzyme ◽

The Effect of Chronic Consumption of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Antagonists on Blood Pressure and Inotrope Consumption After Separation from Cardiopulmonary Bypass

Anesthesiology and Pain Medicine ◽

10.5812/aapm.74026 ◽

2018 ◽

Vol 8 (3) ◽

Cited By ~ 1

Author(s):

Ebrahim Hassani ◽

Alireza Mahoori ◽

Nazli Karami ◽

Asma Hassani ◽

Leila Hassani

Keyword(s):

Blood Pressure ◽

Cardiopulmonary Bypass ◽

Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Receptor Antagonists ◽

Converting Enzyme Inhibitors ◽

Angiotensin Receptor Antagonists

3644 Pleiotropic effect of angiotensin-converting enzyme inhibitors on MMP-9: a key enzyme in cardiac and vascular remodelling

European Heart Journal ◽

10.1016/s0195-668x(03)96228-2 ◽

2003 ◽

Vol 24 (5) ◽

pp. 711

Author(s):

D REINHARDT

Keyword(s):

Enzyme Inhibitors ◽

Pleiotropic Effect ◽

Converting Enzyme ◽

Vascular Remodelling ◽

Converting Enzyme Inhibitors ◽

Key Enzyme

Irbesartan Combined With Conventional Therapy, Including Angiotensin Converting Enzyme Inhibitors, in Heart Failure

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(97)84523-8 ◽

1998 ◽

Vol 31 (2) ◽

pp. 188A ◽

Cited By ~ 4

Author(s):

M Tonkon

Keyword(s):

Heart Failure ◽

Conventional Therapy ◽

Enzyme Inhibitors ◽

Converting Enzyme ◽

Spectrophotometric Determination of Some Angiotensin Converting Enzyme Inhibitors By Potassium Dichromate and Potassium Permanganate in Tablet Dosage Form

Asian Journal of Biomedical and Pharmaceutical Sciences ◽

10.15272/ajbps.v4i39.642 ◽

2014 ◽

Vol 4 (39) ◽

pp. 16-24 ◽

Cited By ~ 2

Author(s):

Horria A. Mohamed

Keyword(s):

Potassium Permanganate ◽

Dosage Form ◽

Enzyme Inhibitors ◽

Potassium Dichromate ◽

Converting Enzyme ◽

Converting Enzyme Inhibitors ◽

Tablet Dosage

Nephroprotective therapy with angiotensin converting enzyme inhibitors effect evaluation on the course of chronic kidney disease in children with urinary system congenital malformations

Nephrology (Saint-Petersburg) ◽

10.24884/1561-6274-2019-23-3-59-64 ◽

2019 ◽

Vol 23 (3) ◽

pp. 59-64

Author(s):

A. M. Mambetova ◽

A. M. Inarokova ◽

N. N. Shabalova ◽

D. V. Bizheva ◽

M. K. Mokaeva ◽

...

Keyword(s):

Chronic Kidney Disease ◽

Kidney Disease ◽

Congenital Malformations ◽

Enzyme Inhibitors ◽

Urinary System ◽

Converting Enzyme ◽

Effect Evaluation ◽

Reactions induced by angiotensin-converting enzyme inhibitors – etiopathogenic, clinical and therapeutic aspects

Alergologia ◽

10.26416/aler.1.1.2017.1240 ◽

2017 ◽

Vol 1 (1) ◽

Cited By ~ 2

Author(s):

Polliana Mihaela Leru

Keyword(s):

Enzyme Inhibitors ◽

Converting Enzyme ◽

Effect of angiotensin-converting enzyme inhibitors on response to erythropoietin in chronic renal failure patients

MedPulse International Journal of Pharmacology ◽

10.26611/10101312 ◽

2020 ◽

Vol 13 (1) ◽

pp. 05-09

Author(s):

A Vinoth Kumar ◽

◽

P KalaiSelvi ◽

Keyword(s):

Renal Failure ◽

Chronic Renal Failure ◽

Enzyme Inhibitors ◽

Converting Enzyme ◽